Prestige Consumer Healthcare Inc. Financial Ratios — PBH

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
Return on Common Equity (%)	- -	148.86	64.14	41.45	35.95	19.14	59.89	-4.98	18.39	17.77	18.47	-7.01	16.92	14.81	11.52
Return on Assets (%)	2.64	3.75	4.11	3.53	3.57	2.02	8.85	-0.99	4.09	4.74	5.79	-2.34	6.28	6.39	5.52
Return on Capital (%)	7.81	10.78	11.41	8.92	8.24	5.63	- -	- -	8.37	9	9.75	- -	10.45	9.86	8.22
Return on Invested Capital (%)	5.28	8	9.18	6.94	7.27	5.98	- -	- -	7.47	8.37	8.74	- -	9.24	9.29	7.87
Gross Margin (%)	51.55	55.43	56.17	56.84	57.95	56.72	55.37	56.94	57.34	58.03	57.11	55.45	55.49	55.76	54.71
EBITDA Margin (%)	25.74	33.08	33.83	31.53	35.22	32.11	33.5	10.04	33.24	34.98	33.41	33.73	33.15	33.35	31.29
Operating Margin (%)	23.31	30.94	31.57	29.04	32.29	29.19	30.29	6.79	30.23	31.78	30.45	30.84	30.43	30.7	28.42
Incremental Operating Margin (%)	25.51	49.75	14.37	16.16	57.58	-3.76	36.41	381	-1,761.85	-44.19	21.71	41.13	226.9	54.91	81.2
Pretax Margin (%)	13.87	17.1	17.03	17.84	19.5	12.57	10.29	-3.9	19.85	21.64	24.15	-8.33	24.53	24.98	23.65
Profit Margin (%)	8.44	10.56	12.16	10.95	12.39	7.87	32.61	-3.67	14.77	17.46	18.9	-7.3	18.6	18.86	17.48
Net Income to Common Margin (%)	8.44	10.56	12.16	10.95	12.39	7.87	32.61	-3.67	14.77	17.46	18.9	-7.3	18.6	18.86	17.48
Effective Tax Rate (%)	39.15	38.22	28.63	38.6	36.44	37.4	- -	- -	25.57	19.32	21.75	- -	24.16	24.49	26.1
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	148.86	64.14	41.45	35.95	19.14	59.89	-4.98	18.39	17.77	18.47	-7.01	16.92	14.81	11.52

Credit (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
Total Debt	1,124	971	934	1,561	1,625	2,194	1,993	1,799	1,767	1,515	1,506	1,367	1,140	1,044	1,045
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	7	8	9	10	6	9	13
LT Debt	1,124	971	934	1,561	1,625	2,194	1,993	1,799	1,760	1,506	1,497	1,357	1,134	1,036	1,033
Total Debt/EBITDA	9.9	4.73	4.62	6.93	5.72	7.74	5.71	18.35	5.52	4.59	4.15	3.59	3.05	2.75	3.07
Net Debt/EBITDA	9.73	4.66	4.48	6.84	5.63	7.6	5.62	18.07	5.11	4.39	3.99	3.38	2.89	2.36	2.74
Total Debt/EBIT	10.93	5.06	4.95	7.52	6.24	8.52	6.32	27.16	6.07	5.05	4.55	3.93	3.33	2.99	3.38
Net Debt/EBIT	10.75	4.98	4.8	7.42	6.14	8.36	6.22	26.75	5.62	4.83	4.38	3.7	3.15	2.56	3.02
EBITDA to Interest Expense	2.75	2.43	2.94	2.77	3.33	3.03	3.28	0.93	3.33	4.01	5.65	5.5	5.56	7.97	8.05
EBITDA-CapEx/Interest Expense	2.73	2.31	2.9	2.7	3.29	3	3.16	0.83	3.15	3.74	5.5	5.39	5.41	7.79	7.78
EBIT to Interest Expense	2.49	2.27	2.75	2.55	3.05	2.75	2.97	0.63	3.03	3.64	5.15	5.03	5.1	7.33	7.31
Interest Expense	41	84	69	81	85	94	106	105	96	82	64	69	67	48	42
Common Equity/Total Assets	0.64	4.41	8.33	8.63	11.12	10.16	19.59	20.41	24.04	29.43	33.09	33.77	40.43	45.75	49.99
Long-Term Debt/Equity (%)	279.07	203.14	165.86	248.76	218.36	266.7	169.09	164.13	150.29	110.89	94.91	93.8	68.49	56.45	54.72
Long-Term Debt/Capital (%)	98.98	92.65	86.19	87.26	83.21	84.67	73.01	71.92	67.39	59.68	55.02	54.3	45.68	39.83	36.99
Long-Term Debt/Total Assets (%)	63.92	55.81	52.04	59.1	55.12	56.09	53	52.27	50.08	43.92	40.79	40.47	34.16	30.44	29.56
Total Debt/Equity (%)	279.07	203.14	165.86	248.76	218.36	266.7	169.09	164.13	150.87	111.51	95.48	94.47	68.86	56.91	55.39
Total Debt/Capital (%)	98.98	92.65	86.19	87.26	83.21	84.67	73.01	71.92	67.65	60.01	55.36	54.69	45.93	40.15	37.44
Total Debt/Total Assets (%)	63.92	55.81	52.04	59.1	55.12	56.09	53	52.27	50.28	44.17	41.04	40.76	34.34	30.69	29.92
Net Debt to Equity	274.35	199.86	160.84	245.36	214.7	261.61	166.33	161.62	139.67	106.56	91.88	88.96	65.21	48.75	49.43
Net Debt/Capital (%)	98.97	92.54	85.82	87.11	82.98	84.42	72.68	71.6	64.99	58.09	53.81	52.74	44.33	35.74	34.2
EBITDA	114	205	202	225	284	283	349	98	320	330	363	380	373	379	341
EBITDA-CapEx	113	195	199	219	280	280	336	88	303	308	353	373	364	371	330
Operating Income (Loss)	103	192	189	208	260	257	315	66	291	300	331	348	342	349	309

Liquidity (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
Cash Ratio	0.3	0.16	0.34	0.22	0.26	0.26	0.26	0.22	0.63	0.26	0.19	0.36	0.4	0.92	0.53
Current Ratio	2.3	1.7	2.1	2.04	2.33	2.06	2.46	2.37	2.44	2.21	2.04	2.44	3.2	4.2	3.57
Quick Ratio	1.24	0.92	1.11	1.1	1.15	1.1	1.41	1.39	1.64	1.2	1.16	1.4	1.91	2.74	2.12
CFO/Avg Current Liab	1.14	1.71	1.23	1.7	1.71	1.11	1.47	1.51	1.57	1.73	1.96	1.51	1.79	2.25	2.26
Common Equity/Total Assets	0.64	4.41	8.33	8.63	11.12	10.16	19.59	20.41	24.04	29.43	33.09	33.77	40.43	45.75	49.99
Long-Term Debt/Equity (%)	279.07	203.14	165.86	248.76	218.36	266.7	169.09	164.13	150.29	110.89	94.91	93.8	68.49	56.45	54.72
Long-Term Debt/Capital (%)	98.98	92.65	86.19	87.26	83.21	84.67	73.01	71.92	67.39	59.68	55.02	54.3	45.68	39.83	36.99
Long-Term Debt/Total Assets (%)	63.92	55.81	52.04	59.1	55.12	56.09	53	52.27	50.08	43.92	40.79	40.47	34.16	30.44	29.56
Total Debt/Equity (%)	279.07	203.14	165.86	248.76	218.36	266.7	169.09	164.13	150.87	111.51	95.48	94.47	68.86	56.91	55.39
Total Debt/Capital (%)	98.98	92.65	86.19	87.26	83.21	84.67	73.01	71.92	67.65	60.01	55.36	54.69	45.93	40.15	37.44
Total Debt/Total Assets (%)	63.92	55.81	52.04	59.1	55.12	56.09	53	52.27	50.28	44.17	41.04	40.76	34.34	30.69	29.92
CFO/Total Liabilities	4.98	10.9	9.05	7.76	8	4.81	8.14	8.07	9.27	11.38	12.42	12.05	14.97	16.05	16.03
CFO/CapEx	111.31	13.4	40.37	25.61	49.41	49.94	16.77	18.06	12.54	10.59	26.96	29.51	26.07	30.58	23.05
Altman's Z-Score	5.25	7.86	8.02	9.17	9.4	6.93	9.67	7.11	7.8	10.02	11.04	9.53	10.75	10.05	8.03

Working Capital (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
Accounts Receivable Turnover	9.26	10.06	8.78	9.58	8.98	7.69	7.56	6.77	6.46	7.13	7.94	6.59	6.11	5.88	5.3
Days Sales Outstanding	39.41	36.29	41.59	38.1	40.63	47.45	48.28	53.9	56.48	51.19	45.96	55.41	59.74	62.09	68.83
Inventory Turnover	4.7	4.97	4.16	4.42	4.1	3.69	3.97	3.52	3.48	3.43	3.96	3.56	3.33	3.51	3.21
Days Inventory Outstanding	77.6	73.5	87.68	82.6	88.96	98.89	91.96	103.55	104.81	106.48	92.12	102.6	109.61	103.86	113.56
Accounts Payable Turnover	9.31	7.31	5.36	6.71	8.44	7.49	7.11	7.15	6.84	7.29	9.27	9.18	9.39	17.69	24.19
Accounts Payable Turnover Days	39.2	49.93	68.07	54.38	43.24	48.76	51.36	51.07	53.34	50.08	39.37	39.74	38.88	20.63	15.09
Cash Conversion Cycle	77.81	59.86	61.2	66.32	86.35	97.57	88.88	106.39	107.95	107.59	98.7	118.27	130.47	145.32	167.3
Inventory to Cash Days	-38.19	-37.22	-46.09	-44.5	-48.33	-51.45	-43.69	-49.65	-48.32	-55.29	-46.16	-47.19	-49.86	-41.77	-44.73
Inventories	51	60	66	74	91	116	119	120	116	115	120	162	139	148	159
Raw Materials	1	2	3	8	8	10	13	17	10	8	17	21	19	27	23
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	3	2
Finished Goods	50	58	62	66	84	105	105	103	106	106	103	141	119	118	134
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
Market Capitalization	879	1,301	1,407	2,238	2,817	2,943	1,790	1,557	1,861	2,213	2,661	3,125	3,610	4,272	- -
- Cash & Cash Equivalents	19	16	28	21	27	42	33	28	95	32	27	58	46	98	64
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	1,124	971	934	1,561	1,625	2,194	1,993	1,799	1,767	1,515	1,506	1,367	1,140	1,044	1,045
Enterprise Value	1,984	2,256	2,313	3,778	4,415	5,095	3,751	3,328	3,532	3,696	4,140	4,433	4,704	5,219	982
Total Capital	1,135	1,048	1,084	1,789	1,953	2,591	2,730	2,501	2,611	2,524	2,721	2,499	2,481	2,601	2,792
Total Debt/Capital (%)	98.98	92.65	86.19	87.26	83.21	84.67	73.01	71.92	67.65	60.01	55.36	54.69	45.93	40.15	37.44
Total Debt / EV	0.57	0.43	0.4	0.41	0.37	0.43	0.53	0.54	0.5	0.41	0.36	0.31	0.24	0.2	1.07
EV/Sales	4.5	3.64	3.87	5.29	5.48	5.78	3.6	3.41	3.67	3.92	3.81	3.93	4.18	4.59	0.9
EV/EBITDA	17.47	11	11.45	16.77	15.54	17.99	10.75	33.96	11.03	11.2	11.4	11.65	12.61	13.75	2.88
EV/EBIT	19.29	11.76	12.26	18.2	16.96	19.79	11.89	50.26	12.13	12.33	12.51	12.75	13.74	14.94	3.17
EV/Cash Flow to Firm	21.42	11.89	14.41	18.32	19.15	24.59	6.86	11.55	12.23	12.24	13.34	15.27	15.69	18.15	3.4
EV/Free Cash Flow to Firm	21.28	11.28	14.16	17.79	18.86	24.24	6.7	11.15	11.54	11.4	12.94	14.87	15.2	17.65	3.27
Diluted Market Cap	887	1,321	1,427	2,259	2,837	2,965	1,805	1,557	1,876	2,231	2,692	3,125	3,641	4,305	- -
Diluted Enterprise Value	1,992	2,277	2,333	3,799	4,435	5,117	3,765	3,328	3,548	3,713	4,171	4,433	4,734	5,252	982
EV per Share	39.46	44.56	44.8	72.41	83.68	96.18	70.64	63.92	69.64	73.6	82.37	88.86	94.53	105.01	- -
TTM Sales	441	620	597	715	806	882	1,041	976	963	943	1,087	1,128	1,125	1,138	1,089
TTM EBITDA	114	205	202	225	284	283	349	98	320	330	363	380	373	379	341
TTM Operating Income	103	192	189	208	260	257	315	66	291	300	331	348	342	349	309
TTM Cash Flow to Firm	93	190	161	206	231	207	547	288	289	302	310	290	300	287	289
TTM Free Cash Flow to Firm	93	200	163	212	234	210	560	299	306	324	320	298	309	296	300

Multiples (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
Price/Free Cash Flow	13.03	8.94	12.48	13.91	15.77	19.55	8.11	7.8	8	8.65	9.98	13.16	14.09	16.58	- -
EV/EBIT	19.29	11.76	12.26	18.2	16.96	19.79	11.89	50.26	12.13	12.33	12.51	12.75	13.74	14.94	3.17
Enterprise Value	1,984	2,256	2,313	3,778	4,415	5,095	3,751	3,328	3,532	3,696	4,140	4,433	4,704	5,219	982
Low Price	8.15	12.5	24.94	25.94	39.1	44.64	32.46	26.25	27.4	32.2	42.7	48.51	52.9	62.35	57.25
EV/Sales	4.5	3.64	3.87	5.29	5.48	5.78	3.6	3.41	3.67	3.92	3.81	3.93	4.18	4.59	0.9
EV/EBITDA	17.47	11	11.45	16.77	15.54	17.99	10.75	33.96	11.03	11.2	11.4	11.65	12.61	13.75	2.88
Price/Earnings	23.61	19.86	19.38	28.59	28.19	42.41	5.27	- -	13.08	13.44	12.96	- -	17.25	19.91	- -
Price/Earnings Average	16.03	14.2	22.02	22.77	25.07	39.9	7.38	-49.76	12.37	11.78	13.46	-34.88	14.64	17.24	- -
Price/Earnings High	24.13	20.37	26.09	28.9	28.65	44.34	9.32	-60.74	16.44	14.63	15.62	-40.88	17.9	20.85	- -
Price/Earnings Low	11.01	9.66	17.74	17.29	20.65	34.08	5.08	-38.18	9.77	9.82	10.45	-29.4	12.57	14.44	- -
Price/Book Value	78.13	16.95	9.4	9.82	8.59	7.41	2.43	2.22	2.2	2.19	2.19	2.76	2.69	2.75	- -
Price/Book Value Average	53.05	12.11	10.68	7.82	7.64	6.97	3.4	2.54	2.08	1.92	2.28	2.54	2.28	2.38	- -
Price/Book Value High	79.83	17.38	12.66	9.92	8.73	7.75	4.3	3.1	2.77	2.39	2.64	2.97	2.79	2.88	- -
Price/Book Value Low	36.43	8.25	8.61	5.94	6.29	5.95	2.34	1.95	1.65	1.6	1.77	2.14	1.96	1.99	- -
Price/Tangible Book Value	-0.75	-1.22	-1.38	-1.24	-1.45	-1.09	-0.81	-0.78	-0.99	-1.31	-1.57	-2.2	-3.03	-4.32	- -
Price/Tangible Book Value Average	-0.51	-0.87	-1.56	-0.99	-1.29	-1.03	-1.13	-0.9	-0.93	-1.14	-1.63	-2.02	-2.57	-3.75	- -
Price/Tangible Book Value High	-0.77	-1.25	-1.85	-1.26	-1.48	-1.14	-1.42	-1.09	-1.24	-1.42	-1.89	-2.37	-3.14	-4.53	- -
Price/Tangible Book Value Low	-0.35	-0.6	-1.26	-0.75	-1.06	-0.88	-0.78	-0.69	-0.74	-0.95	-1.26	-1.7	-2.21	-3.14	- -
Price/Sales	1.99	2.1	2.36	3.13	3.49	3.34	1.72	1.6	1.93	2.35	2.45	2.77	3.21	3.76	- -
Price/Sales Average	1.35	1.5	2.68	2.49	3.11	3.14	2.41	1.83	1.83	2.06	2.54	2.55	2.72	3.25	- -
Price/Sales High	2.04	2.15	3.17	3.17	3.55	3.49	3.04	2.23	2.43	2.55	2.95	2.98	3.33	3.93	- -
Price/Sales Low	0.93	1.02	2.16	1.89	2.56	2.68	1.66	1.4	1.44	1.71	1.97	2.15	2.34	2.72	- -
Price/Cash Flow	13.03	9.45	12.61	14.32	15.97	19.8	8.52	8.23	8.57	9.39	10.24	13.6	14.5	16.99	- -
Price/Cash Flow Average	8.84	6.76	14.33	11.4	14.21	18.62	11.93	9.41	8.1	8.23	10.64	12.5	12.31	14.71	- -
Price/Cash Flow High	13.31	9.7	16.98	14.48	16.23	20.7	15.07	11.49	10.77	10.22	12.34	14.65	15.05	17.79	- -
Price/Cash Flow Low	6.07	4.6	11.54	8.66	11.7	15.91	8.2	7.22	6.4	6.86	8.26	10.54	10.57	12.32	- -
Price/Free Cash Flow Average	8.85	6.39	14.18	11.08	14.03	18.39	11.35	8.92	7.57	7.58	10.38	12.09	11.96	14.36	- -
Price/Free Cash Flow High	13.32	9.17	16.8	14.07	16.03	20.44	14.34	10.88	10.06	9.42	12.04	14.17	14.62	17.36	- -
Price/Free Cash Flow Low	6.08	4.35	11.42	8.42	11.55	15.71	7.8	6.84	5.98	6.32	8.05	10.19	10.27	12.02	- -
EV/Sales Average	3.86	3.04	4.19	4.65	5.09	5.58	4.29	3.64	3.56	3.63	3.91	3.71	3.69	4.08	0.9
EV/Sales High	4.54	3.69	4.69	5.32	5.53	5.93	4.92	4.04	4.17	4.13	4.31	4.14	4.3	4.76	0.9
EV/Sales Low	3.43	2.56	3.67	4.05	4.54	5.12	3.54	3.22	3.18	3.28	3.34	3.31	3.31	3.56	0.9
EV/EBITDA Average	14.99	9.19	12.4	14.74	14.45	17.37	12.81	36.25	10.72	10.37	11.69	10.99	11.14	12.25	2.88
EV/EBITDA High	17.64	11.16	13.86	16.88	15.7	18.46	14.7	40.26	12.53	11.79	12.91	12.29	12.97	14.29	2.88
EV/EBITDA Low	13.34	7.74	10.86	12.84	12.89	15.95	10.56	32.02	9.56	9.39	9.98	9.8	9.98	10.66	2.88
EV/EBIT Average	16.55	9.83	13.28	16	15.76	19.11	14.17	53.65	11.79	11.41	12.82	12.02	12.14	13.31	3.17
EV/EBIT High	19.48	11.93	14.85	18.32	17.13	20.31	16.25	59.58	13.78	12.98	14.16	13.44	14.14	15.52	3.17
EV/EBIT Low	14.73	8.28	11.63	13.94	14.06	17.54	11.68	47.39	10.52	10.34	10.95	10.72	10.88	11.58	3.17
Last Price	17.48	25.69	27.25	42.89	53.39	55.56	33.72	29.91	36.68	44.08	52.94	62.63	72.56	85.97	59.27
High Price	17.86	26.35	36.69	43.36	54.25	58.08	59.63	41.76	46.12	47.98	63.82	67.45	75.31	90.04	89.37
Enterprise Value Average	1,702	1,885	2,505	3,322	4,103	4,921	4,468	3,552	3,431	3,422	4,244	4,180	4,158	4,647	982
Enterprise Value High	2,003	2,290	2,801	3,802	4,460	5,229	5,127	3,945	4,011	3,891	4,687	4,674	4,840	5,421	982
Enterprise Value Low	1,515	1,588	2,194	2,893	3,661	4,517	3,684	3,138	3,062	3,099	3,625	3,729	3,725	4,045	982

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
Shares Outstanding	50	51	52	52	53	53	53	52	50	50	50	50	50	50	47
Diluted Weighted Avg Shares	51	51	52	53	53	53	54	52	51	51	51	50	50	50	- -
Basic Weighted Avg Shares	50	51	52	52	53	53	53	52	51	50	50	50	50	50	- -
Revenue per Share	8.77	12.25	11.57	13.7	15.28	16.65	19.61	18.74	18.99	18.79	21.62	22.6	22.62	22.89	- -
EBITDA per Share	2.26	4.05	3.91	4.32	5.38	5.35	6.57	1.88	6.31	6.57	7.22	7.63	7.5	7.63	- -
Operating Income per Share	2.05	3.79	3.65	3.98	4.93	4.86	5.94	1.27	5.74	5.97	6.59	6.97	6.88	7.03	- -
Basic EPS, GAAP	0.74	1.29	1.41	1.5	1.89	1.31	6.4	-0.69	2.81	3.28	4.09	-1.65	4.21	4.32	- -
Basic EPS from Cont Ops	0.74	1.29	1.41	1.5	1.89	1.31	6.4	-0.69	2.81	3.28	4.09	-1.65	4.21	4.32	- -
Diluted EPS, GAAP	0.73	1.27	1.39	1.49	1.88	1.3	6.34	-0.69	2.78	3.25	4.04	-1.65	4.17	4.29	- -
Diluted EPS from Cont Ops	0.73	1.27	1.39	1.49	1.88	1.3	6.34	-0.69	2.78	3.25	4.04	-1.65	4.17	4.29	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	1.34	2.72	2.16	3	3.34	2.81	3.96	3.64	4.28	4.69	5.17	4.6	5	5.06	- -
Free Cash Flow per Basic Share	1.33	2.51	2.11	2.88	3.27	2.75	3.72	3.43	3.94	4.25	4.98	4.45	4.81	4.9	- -
Cash & Equivalents per Share	0.38	0.31	0.55	0.41	0.52	0.79	0.61	0.53	1.87	0.64	0.54	1.17	0.93	1.97	- -
Book Value per Share	0.22	1.52	2.9	4.37	6.21	7.5	13.88	13.49	16.65	20.1	24.17	22.7	26.97	31.32	- -
Tangible Book Value per Share	-23.31	-21	-19.8	-34.46	-36.75	-50.9	-41.85	-38.22	-37.14	-33.77	-33.78	-28.51	-23.98	-19.88	- -

Prestige Consumer Healthcare Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)